![J. Marc Simard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. Marc Simard
Director/Miembro de la Junta en Remedy Pharmaceuticals, Inc. .
Perfil
Dr. J.
M.
Simard is on the Board of Directors at Remedy Pharmaceuticals, Inc.
Dr. Simard was previously employed as an Advisory Board Member by Carrot Capital LLC.
He received his undergraduate degree from St. Anselm College and a doctorate degree from Creighton University.
Cargos activos de J. Marc Simard
Empresas | Cargo | Inicio |
---|---|---|
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de J. Marc Simard.
Empresas | Cargo | Fin |
---|---|---|
Embark Healthcare
![]() Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Formación de J. Marc Simard.
St. Anselm College | Undergraduate Degree |
Creighton University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Embark Healthcare
![]() Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- J. Marc Simard